Abstract: During early phase drug safety trials in humans, prolongation of the rate-corrected QT interval has become a surrogate marker for heterogeneity of ventricular repolarization that can cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback